As of Feb 28, 2025
ProShares Ultra Nasdaq Biotechnology (NASDAQ: BIB)
The BIB ETF is currently trading at $53.99, which represents a 3.25% change. Over the past 52 weeks, the ETF has traded as high as $69.56 and as low as $47.20.
The expense ratio of BIB is 0.95%. This represents the annual fee that all funds or ETFs charge their shareholders.
The total Assets Under Management (AUM) for BIB is 60.83M. This represents the total market value of the assets managed by the ETF.
BIB follows a Trading-Leveraged Equity investment style.
The top holdings of BIB include: GILD (5.6%), REGN (5.21%), VRTX (6.23%), AMGN (6.62%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for BIB is currently not available.